tevogen.com (TVGN) - Kewajiban jangka dawa marang modal

tevogen.com - logo grafis emiten TVGN

This price action chart for Tevogen Bio Holdings (TVGN) demonstrates a metric of 0.00, which correlates with the potential for premium pricing power when bringing innovative T-cell therapies to market. The business focuses on developing immune solutions against oncology and viruses, enhancing the body's ability to combat pathologies. Furthermore, project development remains independent of economic cycles, although it is sensitive to borrowing costs.

Tevogen Bio Holdings Inc. (TVGN): Utang jangka dawa marang ekuitas saka 21.02.2024 nganti 31.10.2026
Produk asli Tevogen Bio Inc.

For Tevogen Bio Holdings (TVGN), whose cell therapy developments remain independent of economic cycles, the share of long-term loans within the capital structure on GURU.Markets reflects the funding stability of its long-term programs. This ratio compares liabilities with a maturity of over one year against equity, allowing investors to assess financial leverage and the business's sensitivity to changes in market interest rates.

Perusahaan pesaing

Rasio utang jangka dawa marang modal BIIB (Biogen Inc)|Utang jangka dawa marang modal NBIX|RGC - Kewajiban jangka dawa marang modal|Axsome Therapeutics - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal acadia-pharm.com ACAD|XENE - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Catalyst Corp (CPRX)|Rasio utang jangka dawa marang ekuitas DNLI|HRMY (harmonybiosciences.com) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal BHVN|AMLX - Kewajiban jangka dawa marang modal|Trevi Pharma - Rasio utang jangka dawa marang ekuitas|Praxis Corp - Utang jangka dawa marang ekuitas|AVXL - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal ceribell.com|PRTA: Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Alector ALEC|ANNX (Annexon Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Omeros Corp. OMER|Utang jangka dawa marang ekuitas Neurogene Inc. (NGNE)|acimmune.com - Rasio utang jangka dawa marang modal|Voyager Therapeutics, Inc. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal NMRA|Scilex Holding Co. - Utang jangka dawa marang modal|ACOG: Utang jangka dawa marang ekuitas|CGTX: Utang jangka dawa marang modal|IKT - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Cassava Sciences|Kewajiban jangka dawa marang modal Assertio Therapeutics ASRT|Rasio utang jangka dawa marang ekuitas COYA (Coya Therapeutics, Inc.)|VTGN (vistagen.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal OVID (Ovid Therapeutics)|Koefisien utang jangka dawa marang modal ABOS|CRVO - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Alterity Therapeutics|clene.com (CLNN) - Utang jangka dawa marang ekuitas|PEPG (PepGen) - Utang jangka dawa marang ekuitas|JUNS (Jupiter Neurosciences Inc) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal RLMD (relmada.com)|Utang jangka dawa marang modal ANVS|Rasio tanggungan utang jangka dawa marang modal gracetx.com|Utang jangka dawa marang ekuitas Firefly Neuroscience Inc AIFF|KLTO: Rasio utang jangka dawa marang modal|NeuroSense Therapeutics, Ltd. - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas revivapharma.com (RVPH)|metaviatx.com (MTVA) - Utang jangka dawa marang ekuitas|NRXS - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas HSDT|PASG (Passage Bio Corp) - Rasio silihan jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas NEUP (Neuphoria Therapeutics Inc.)|Utang jangka dawa marang ekuitas NERV (minervaneurosciences.com)|Utang jangka dawa marang modal ATHA (Athira Pharma)|Tanggungan utang jangka dawa marang ekuitas Addex Therapeutics Ltd.|ALZN - Utang jangka dawa marang ekuitas|CYCN (Cyclerion Therapeutics) - Rasio utang jangka dawa marang modal|protagenic.com (PTIX) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal KTTA|CRGT (Cortigent Inc) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Avenue Therapeutics Inc. ATXI|Rasio utang jangka dawa marang ekuitas BCLI (Brainstorm Cell Therapeutics, Inc.)|Utang jangka dawa marang modal Cara Therapeutics Inc (CARA)|Utang jangka dawa marang ekuitas Chromocell Therapeutics CHRO|Koefisien utang jangka dawa marang modal ELYM|ITCI - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Longboard Pharmaceuticals Inc|MRNS (Marinus) - Rasio utang jangka dawa marang ekuitas|NKGN: Rasio silihan jangka dawa marang modal|NRBO (NeuroBo Pharmaceuticals) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal sagerx.com SAGE|Rasio utang jangka dawa marang ekuitas SNPX (Synaptogenix)|Utang jangka dawa marang ekuitas TRVN (Trevena Inc.)|Utang jangka dawa marang ekuitas Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Kewajiban jangka dawa marang modal|Cerevel Therapeutics - Utang jangka dawa marang modal